ABSI logo

Absci Corporation Common Stock


ABSI: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.


Show ABSI Financials

Consumer Interest
SEC Filings

Recent trades of ABSI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ABSI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: C-peptides and proinsulin polypeptides comprising the same Feb. 21, 2023
  • Patent Title: Host cells for use in an inducible coexpression system Sep. 20, 2022
  • Patent Title: Vectors for use in an inducible coexpression system Jun. 28, 2022
  • Patent Title: Coordinated coexpression of thrombin Dec. 17, 2019
  • Patent Title: Inducible coexpression system Apr. 11, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ABSI in WallStreetBets Daily Discussion


Recent insights relating to ABSI

CNBC Recommendations

Recent picks made for ABSI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABSI

Corporate Flights

Flights by private jets registered to ABSI